
    
      The MODULAR ATP Clinical Study will enroll subjects with a standard Implantable Cardioverter
      Defibrillator (ICD) indication applying international practice guidelines, as well as those
      who already have an implanted S-ICD System and satisfy the inclusion criteria for this study,
      while not meeting any exclusion criteria. Subjects will be followed for at least 6 months
      following mCRM Therapy System implantation.
    
  